Skip to main content
. 1999 Feb 6;318(7180):380–384. doi: 10.1136/bmj.318.7180.380

Table 2.

Drugs for second line, additive control of asthma

Drug Route and frequency Therapeutic ratio Anti-inflammatory activity Symptom control Tolerance Cost
Long acting β2 agonist Inhaled, twice daily* High None Good Yes Expensive
Theophylline Oral, twice daily Low Weak Moderate No Cheap
Leukotriene antagonist Oral, once or twice daily High Moderate Good No Expensive
*

May be used once daily for nocturnal symptoms.